Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett's esophagus surveillance program

Digestive Diseases and Sciences

Volumn 58, Issue 1, 2013, Pages 188-193

  Bertani, Helga ^a   Frazzoni, Marzio ^a   Dabizzi, Emanuele ^a   Pigò, Flavia ^a   Losi, Luisa ^b   Manno, Mauro ^a   Manta, Raffaele ^a   Bassotti, Gabrio ^c   Conigliaro, Rita ^a  

^a Nuovo Ospedale S Agostino   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Clinica di Gastroenterologia Ed Epatologia   (Italy)

Author keywords

Barrett's esophagus; Confocal laser endomicroscopy; Esophageal adenocarcinoma; Esophageal dysplasia

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ESOPHAGUS BIOPSY; ESOPHAGUS DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; PROBE BASED CONFOCAL LASER ENDOMICROSCOPY; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; WHITE LIGHT ENDOSCOPY;

BARRETT ESOPHAGUS; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY;

EID: 84873140554     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2332-z     Document Type: Article

References (30)

1. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 2008;103:788-797.
2. Prasad GA, Bansal A, Sharma P, et al. Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol. 2010;105:1490-1502.
3. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011;140:1084-1091.
4. Boyer J, Laugier R, Chemali M, et al. French Society of Digestive Endoscopy guideline: monitoring of patients with Barrett's esophagus. Endoscopy. 2007;39:840-842.
5. Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154-1161.
6. Abela JE, Going JJ, Mackenzie JF, et al. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol. 2008;103:850-855.
7. Kariv R, Plesec TP, Goldblum JR, et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol. 2009;7:653-658.
8. Kiesslich R, Gossner L, Goetz M, et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol. 2006;4:979-987.
9. Dunbar KB, Okolo P, Montgomery E, Canto MI. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc. 2009;70:645-654.
10. Pohl H, Rosch T, Vieth M, et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's esophagus. Gut. 2008;57:1648-1653.
11. Wallace MB, Sharma P, Lightdale C, et al. Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett's esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc. 2010;72:19-24.
12. Bajbouj M, Vieth M, Rosch T, et al. Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy. 2010;42:435-440.
13. Frazzoni M, Savarino E, Manno M, et al. Reflux patterns in patients with short segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther. 2009;30:508-515.
14. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172-180.
15. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392-1399.
16. Wallace M, Lauwers GY, Chen Y, et al. Miami classification for probe-based confocal laser endomicroscopy. Endoscopy. 2011;43:882-891.
17. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994;25:982-993.
18. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368-378.
19. Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011;140:e18-e52.
20. Sharma P, Meining A, Coron E, et al. Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc. 2011;74:465-472.
21. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831.
22. Zagari RM, Fuccio L, Wallander M-A, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57:1354-1359.
23. Iftikhar SY, James PD, Steele RJ, et al. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut. 1992;33:1155-1158.
24. Wolfsen HC, Hemminger LL, Wallace MB, et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther. 2004;20:1125-1131.
25. Wani S, Falk JW, Hall M, et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011;9:220-227.
26. Sikkema M, Looman CWN, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett' s esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106:1231-1238.
27. Lim CH, Treanor D, Dixon MF, et al. Low grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy. 2007;39:581-587.
28. Curvers WL, Kate FJ, Krishnadath KK, et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am J Gastroenterol. 2010;105:1523-1530.
29. Wani S, Falk JW, Post J, et al. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology. 2011;141:1179-1186.
30. Hvid-Jensen F, Pedersen L, Mohr Drewes A, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med. 2011;365:1375-1383.